The company explained that, in a comparison of the effects of YH35324 and Xolair in patients with chronic spontaneous urticaria (CSU), patients administered YH35324 showed ... It hopes that the stem ...

THB335 Phase 1 data support advancement into Phase 2 clinical trial in chronic spontaneous urticaria (CSU)Company initiating process to leverage ...

The MAD cohort also saw adverse events such as hair loss and reductions in hemoglobin and neutrophil counts. These side ...

Celldex has a strong cash position with a runway of 13-14 quarters, bolstered by a $424 million secondary offering in March 2024. Learn more on CLDX stock here.

What if the food you eat and the way you handle stress could make a real difference for your chronic spontaneous urticaria?

Abstract Title: Briquilimab Potently Inhibits Stem Cell Factor (SCF)/c-Kit Signaling and Induces Mast Cell Apoptosis Poster Number: 541 Session Title: Novel Mechanisms of Mast Cells, Basophils and IgE ...

Incyte Reports 2024 Fourth Quarter and Year-End Financial Results, Provides 2025 Financial Guidance and Highlights 2025 R&D ...

Medically reviewed by Brendan Camp, MD Hives and eczema are two of the most common skin disorders. Hives, clinically known as ...

Hives, also known as urticaria, are raised, itchy welts on your skin that occur due to an allergen. The reaction is ...

ALY-101 is an intradermal injectable JAK1 siRNA-lipid conjugate for the treatment of Alopecia Areata Significant progress made in ... of assets targeting unmet needs in additional indications such as ...

Revolutionizing Chronic Urticaria Treatment: The Impact of Targeted Therapy The treatment of chronic urticaria (CU), a condition highlighted by constant itching and hives, is undergoing a notable ...